These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 27770736)

  • 1. Synthesis and evaluation of in vitro antiproliferative activity of new ethyl 3-(arylethynyl)quinoxaline-2-carboxylate and pyrido[4,3-b]quinoxalin-1(2H)-one derivatives.
    Hajri M; Esteve MA; Khoumeri O; Abderrahim R; Terme T; Montana M; Vanelle P
    Eur J Med Chem; 2016 Nov; 124():959-966. PubMed ID: 27770736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of the cytotoxic activity of novel ethyl 4-[4-(4-substitutedpiperidin-1-yl)]benzyl-phenylpyrrolo[1,2-a]quinoxaline-carboxylate derivatives in myeloid and lymphoid leukemia cell lines.
    Desplat V; Vincenzi M; Lucas R; Moreau S; Savrimoutou S; Pinaud N; Lesbordes J; Peyrilles E; Marchivie M; Routier S; Sonnet P; Rossi F; Ronga L; Guillon J
    Eur J Med Chem; 2016 May; 113():214-27. PubMed ID: 26945110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of the antiproliferative activity of novel isoindolo[2,1-a]quinoxaline and indolo[1,2-a]quinoxaline derivatives.
    Desplat V; Moreau S; Belisle-Fabre S; Thiolat D; Uranga J; Lucas R; de Moor L; Massip S; Jarry C; Mossalayi DM; Sonnet P; Déléris G; Guillon J
    J Enzyme Inhib Med Chem; 2011 Oct; 26(5):657-67. PubMed ID: 21250818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of N-substituted 3-oxo-1,2,3,4-tetrahydro-quinoxaline-6-carboxylic acid derivatives as tubulin polymerization inhibitors.
    Qi J; Dong H; Huang J; Zhang S; Niu L; Zhang Y; Wang J
    Eur J Med Chem; 2018 Jan; 143():8-20. PubMed ID: 29172084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular modeling studies and synthesis of novel quinoxaline derivatives with potential anticancer activity as inhibitors of c-Met kinase.
    Abbas HA; Al-Marhabi AR; Eissa SI; Ammar YA
    Bioorg Med Chem; 2015 Oct; 23(20):6560-72. PubMed ID: 26420384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and in vitro antitumor activity of new quinoxaline derivatives.
    Corona P; Carta A; Loriga M; Vitale G; Paglietti G
    Eur J Med Chem; 2009 Apr; 44(4):1579-91. PubMed ID: 18774202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aza-isoindolo and isoindolo-azaquinoxaline derivatives with antiproliferative activity.
    Parrino B; Carbone A; Spanò V; Montalbano A; Giallombardo D; Barraja P; Attanzio A; Tesoriere L; Sissi C; Palumbo M; Cirrincione G; Diana P
    Eur J Med Chem; 2015 Apr; 94():367-77. PubMed ID: 25778992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of [1,2,4]triazolo[4,3-a]quinoxaline-1,3,4-oxadiazole derivatives as potent antiproliferative agents via a hybrid pharmacophore approach.
    Kaneko D; Ninomiya M; Yoshikawa R; Ono Y; Sonawane AD; Tanaka K; Nishina A; Koketsu M
    Bioorg Chem; 2020 Nov; 104():104293. PubMed ID: 33010622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and Synthesis of New Quinoxaline Derivatives as Anticancer Agents and Apoptotic Inducers.
    El Newahie AMS; Nissan YM; Ismail NSM; Abou El Ella DA; Khojah SM; Abouzid KAM
    Molecules; 2019 Mar; 24(6):. PubMed ID: 30934622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of amino-substituted benzo[f]pyrido[4,3-b] and pyrido[3,4-b]quinoxalines: a new class of antineoplastic agents.
    Nguyen CH; Fan E; Riou JF; Bissery MC; Vrignaud P; Lavelle F; Bisagni E
    Anticancer Drug Des; 1995 Jun; 10(4):277-97. PubMed ID: 7786395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New imidazo[1,2-a]quinoxaline derivatives: synthesis and in vitro activity against human melanoma.
    Deleuze-Masquefa C; Moarbess G; Khier S; David N; Gayraud-Paniagua S; Bressolle F; Pinguet F; Bonnet PA
    Eur J Med Chem; 2009 Sep; 44(9):3406-11. PubMed ID: 19278757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and anticancer activity evaluation of new 2-alkylcarbonyl and 2-benzoyl-3-trifluoromethyl-quinoxaline 1,4-di-N-oxide derivatives.
    Zarranz B; Jaso A; Aldana I; Monge A
    Bioorg Med Chem; 2004 Jul; 12(13):3711-21. PubMed ID: 15186857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and biological evaluation of (E)-2-(2-arylhydrazinyl)quinoxalines, a promising and potent new class of anticancer agents.
    Rodrigues FA; Bomfim Ida S; Cavalcanti BC; Pessoa Cdo Ó; Wardell JL; Wardell SM; Pinheiro AC; Kaiser CR; Nogueira TC; Low JN; Gomes LR; de Souza MV
    Bioorg Med Chem Lett; 2014 Feb; 24(3):934-9. PubMed ID: 24398294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of indeno[1,2-b]quinoxaline derivatives as potential anticancer agents.
    Tseng CH; Chen YR; Tzeng CC; Liu W; Chou CK; Chiu CC; Chen YL
    Eur J Med Chem; 2016 Jan; 108():258-273. PubMed ID: 26686931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and in vitro antitumor activity of substituted quinazoline and quinoxaline derivatives: search for anticancer agent.
    Noolvi MN; Patel HM; Bhardwaj V; Chauhan A
    Eur J Med Chem; 2011 Jun; 46(6):2327-46. PubMed ID: 21458891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of tumor cell growth inhibition of methyl 3-amino-6-[(hetero)arylethynyl]thieno[3,2-b]pyridine-2-carboxylates. Structure-activity relationships, effects on the cell cycle and apoptosis.
    Queiroz MJ; Calhelha RC; Vale-Silva LA; Pinto E; Almeida GM; Vasconcelos MH
    Eur J Med Chem; 2011 Jan; 46(1):236-40. PubMed ID: 21138784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and Antiproliferative Effect of Ethyl 4-[4-(4-Substituted Piperidin-1-yl)]benzylpyrrolo[1,2-a]quinoxalinecarboxylate Derivatives on Human Leukemia Cells.
    Desplat V; Vincenzi M; Lucas R; Moreau S; Savrimoutou S; Rubio S; Pinaud N; Bigat D; Enriquez E; Marchivie M; Routier S; Sonnet P; Rossi F; Ronga L; Guillon J
    ChemMedChem; 2017 Jun; 12(12):940-953. PubMed ID: 28218826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, cytotoxic evaluation, and QSAR study of some 6H-indolo[2,3-b]quinoxaline derivatives.
    Moorthy NS; Karthikeyan C; Trivedi P
    J Enzyme Inhib Med Chem; 2010 Jun; 25(3):394-405. PubMed ID: 20233012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulphonamido-quinoxalines: search for anticancer agent.
    Ingle R; Marathe R; Magar D; Patel HM; Surana SJ
    Eur J Med Chem; 2013 Jul; 65():168-86. PubMed ID: 23708011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinoxaline chemistry. Part 16. 4-substituted anilino and 4-substituted phenoxymethyl pyrrolo[1,2-a]quinoxalines and N-[4-(pyrrolo[1,2-a]quinoxalin-4-yl)amino and hydroxymethyl]benzoyl glutamates. Synthesis and evaluation of in vitro biological activity.
    Alleca S; Corona P; Loriga M; Paglietti G; Loddo R; Mascia V; Busonera B; La Colla P
    Farmaco; 2003 Sep; 58(9):639-50. PubMed ID: 13679156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.